nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—Telmisartan—PPARG—Alzheimer's disease	0.0042	0.325	CrCbGaD
Olmesartan—Candesartan—PTGS1—Alzheimer's disease	0.0025	0.194	CrCbGaD
Olmesartan—Irbesartan—PTGS1—Alzheimer's disease	0.0025	0.194	CrCbGaD
Olmesartan—Urinary tract infection—Donepezil—Alzheimer's disease	0.0022	0.00274	CcSEcCtD
Olmesartan—Angina pectoris—Rivastigmine—Alzheimer's disease	0.0022	0.00273	CcSEcCtD
Olmesartan—Muscle spasms—Galantamine—Alzheimer's disease	0.00219	0.00273	CcSEcCtD
Olmesartan—Pancytopenia—Memantine—Alzheimer's disease	0.00219	0.00273	CcSEcCtD
Olmesartan—Bronchitis—Rivastigmine—Alzheimer's disease	0.00217	0.0027	CcSEcCtD
Olmesartan—Haematuria—Donepezil—Alzheimer's disease	0.00216	0.00269	CcSEcCtD
Olmesartan—Neutropenia—Memantine—Alzheimer's disease	0.00216	0.00268	CcSEcCtD
Olmesartan—Vision blurred—Galantamine—Alzheimer's disease	0.00215	0.00268	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00214	0.00267	CcSEcCtD
Olmesartan—Erectile dysfunction—Memantine—Alzheimer's disease	0.00212	0.00264	CcSEcCtD
Olmesartan—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00212	0.00264	CcSEcCtD
Olmesartan—Anaemia—Galantamine—Alzheimer's disease	0.00211	0.00263	CcSEcCtD
Olmesartan—Agitation—Galantamine—Alzheimer's disease	0.0021	0.00261	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.0021	0.00261	CcSEcCtD
Olmesartan—Hyperglycaemia—Memantine—Alzheimer's disease	0.00208	0.00259	CcSEcCtD
Olmesartan—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00208	0.00259	CcSEcCtD
Olmesartan—Pneumonia—Memantine—Alzheimer's disease	0.00207	0.00257	CcSEcCtD
Olmesartan—Malaise—Galantamine—Alzheimer's disease	0.00206	0.00256	CcSEcCtD
Olmesartan—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00206	0.00256	CcSEcCtD
Olmesartan—Infestation NOS—Memantine—Alzheimer's disease	0.00206	0.00256	CcSEcCtD
Olmesartan—Infestation—Memantine—Alzheimer's disease	0.00206	0.00256	CcSEcCtD
Olmesartan—Vertigo—Galantamine—Alzheimer's disease	0.00205	0.00255	CcSEcCtD
Olmesartan—Syncope—Galantamine—Alzheimer's disease	0.00205	0.00255	CcSEcCtD
Olmesartan—Rhinitis—Donepezil—Alzheimer's disease	0.00204	0.00254	CcSEcCtD
Olmesartan—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00203	0.00253	CcSEcCtD
Olmesartan—Pneumonia—Rivastigmine—Alzheimer's disease	0.00202	0.00252	CcSEcCtD
Olmesartan—Renal failure—Memantine—Alzheimer's disease	0.00202	0.00252	CcSEcCtD
Olmesartan—Palpitations—Galantamine—Alzheimer's disease	0.00202	0.00251	CcSEcCtD
Olmesartan—Pharyngitis—Donepezil—Alzheimer's disease	0.00202	0.00251	CcSEcCtD
Olmesartan—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00201	0.0025	CcSEcCtD
Olmesartan—Infestation—Rivastigmine—Alzheimer's disease	0.00201	0.0025	CcSEcCtD
Olmesartan—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00201	0.0025	CcSEcCtD
Olmesartan—Loss of consciousness—Galantamine—Alzheimer's disease	0.00201	0.0025	CcSEcCtD
Olmesartan—Losartan—ACE—Alzheimer's disease	0.002	0.155	CrCbGaD
Olmesartan—Oedema peripheral—Donepezil—Alzheimer's disease	0.002	0.00249	CcSEcCtD
Olmesartan—Urinary tract infection—Memantine—Alzheimer's disease	0.002	0.00249	CcSEcCtD
Olmesartan—Urethral disorder—Donepezil—Alzheimer's disease	0.00199	0.00248	CcSEcCtD
Olmesartan—Cough—Galantamine—Alzheimer's disease	0.00199	0.00248	CcSEcCtD
Olmesartan—Renal failure—Rivastigmine—Alzheimer's disease	0.00198	0.00246	CcSEcCtD
Olmesartan—Haematuria—Memantine—Alzheimer's disease	0.00196	0.00244	CcSEcCtD
Olmesartan—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00195	0.00243	CcSEcCtD
Olmesartan—Arthralgia—Galantamine—Alzheimer's disease	0.00194	0.00242	CcSEcCtD
Olmesartan—Chest pain—Galantamine—Alzheimer's disease	0.00194	0.00242	CcSEcCtD
Olmesartan—Myalgia—Galantamine—Alzheimer's disease	0.00194	0.00242	CcSEcCtD
Olmesartan—Anxiety—Galantamine—Alzheimer's disease	0.00194	0.00241	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00193	0.0024	CcSEcCtD
Olmesartan—Sinusitis—Memantine—Alzheimer's disease	0.00193	0.0024	CcSEcCtD
Olmesartan—Discomfort—Galantamine—Alzheimer's disease	0.00192	0.00239	CcSEcCtD
Olmesartan—Agranulocytosis—Memantine—Alzheimer's disease	0.00192	0.00239	CcSEcCtD
Olmesartan—Haematuria—Rivastigmine—Alzheimer's disease	0.00192	0.00239	CcSEcCtD
Olmesartan—Sinusitis—Rivastigmine—Alzheimer's disease	0.00189	0.00235	CcSEcCtD
Olmesartan—Rhinitis—Memantine—Alzheimer's disease	0.00185	0.0023	CcSEcCtD
Olmesartan—Shock—Galantamine—Alzheimer's disease	0.00183	0.00228	CcSEcCtD
Olmesartan—Pharyngitis—Memantine—Alzheimer's disease	0.00183	0.00228	CcSEcCtD
Olmesartan—Nervous system disorder—Galantamine—Alzheimer's disease	0.00183	0.00227	CcSEcCtD
Olmesartan—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00182	0.00227	CcSEcCtD
Olmesartan—Urinary tract disorder—Memantine—Alzheimer's disease	0.00182	0.00227	CcSEcCtD
Olmesartan—Tachycardia—Galantamine—Alzheimer's disease	0.00182	0.00226	CcSEcCtD
Olmesartan—Oedema peripheral—Memantine—Alzheimer's disease	0.00182	0.00226	CcSEcCtD
Olmesartan—Arrhythmia—Donepezil—Alzheimer's disease	0.00182	0.00226	CcSEcCtD
Olmesartan—Connective tissue disorder—Memantine—Alzheimer's disease	0.00181	0.00226	CcSEcCtD
Olmesartan—Rhinitis—Rivastigmine—Alzheimer's disease	0.00181	0.00225	CcSEcCtD
Olmesartan—Skin disorder—Galantamine—Alzheimer's disease	0.00181	0.00225	CcSEcCtD
Olmesartan—Urethral disorder—Memantine—Alzheimer's disease	0.00181	0.00225	CcSEcCtD
Olmesartan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.0018	0.00224	CcSEcCtD
Olmesartan—Alopecia—Donepezil—Alzheimer's disease	0.0018	0.00224	CcSEcCtD
Olmesartan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00179	0.00223	CcSEcCtD
Olmesartan—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00178	0.00222	CcSEcCtD
Olmesartan—Mental disorder—Donepezil—Alzheimer's disease	0.00178	0.00222	CcSEcCtD
Olmesartan—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00178	0.00221	CcSEcCtD
Olmesartan—Anorexia—Galantamine—Alzheimer's disease	0.00178	0.00221	CcSEcCtD
Olmesartan—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00177	0.00221	CcSEcCtD
Olmesartan—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00177	0.0022	CcSEcCtD
Olmesartan—Malnutrition—Donepezil—Alzheimer's disease	0.00177	0.0022	CcSEcCtD
Olmesartan—Hypotension—Galantamine—Alzheimer's disease	0.00174	0.00217	CcSEcCtD
Olmesartan—Back pain—Donepezil—Alzheimer's disease	0.00171	0.00213	CcSEcCtD
Olmesartan—Irbesartan—CYP2D6—Alzheimer's disease	0.0017	0.132	CrCbGaD
Olmesartan—Muscle spasms—Donepezil—Alzheimer's disease	0.0017	0.00212	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.0017	0.00211	CcSEcCtD
Olmesartan—Insomnia—Galantamine—Alzheimer's disease	0.00168	0.0021	CcSEcCtD
Olmesartan—Angiopathy—Memantine—Alzheimer's disease	0.00167	0.00208	CcSEcCtD
Olmesartan—Vision blurred—Donepezil—Alzheimer's disease	0.00167	0.00208	CcSEcCtD
Olmesartan—Mediastinal disorder—Memantine—Alzheimer's disease	0.00166	0.00207	CcSEcCtD
Olmesartan—Arrhythmia—Memantine—Alzheimer's disease	0.00165	0.00205	CcSEcCtD
Olmesartan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00164	0.00204	CcSEcCtD
Olmesartan—Dyspepsia—Galantamine—Alzheimer's disease	0.00164	0.00204	CcSEcCtD
Olmesartan—Angiopathy—Rivastigmine—Alzheimer's disease	0.00164	0.00204	CcSEcCtD
Olmesartan—Anaemia—Donepezil—Alzheimer's disease	0.00163	0.00204	CcSEcCtD
Olmesartan—Alopecia—Memantine—Alzheimer's disease	0.00163	0.00203	CcSEcCtD
Olmesartan—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00163	0.00203	CcSEcCtD
Olmesartan—Agitation—Donepezil—Alzheimer's disease	0.00163	0.00202	CcSEcCtD
Olmesartan—Decreased appetite—Galantamine—Alzheimer's disease	0.00162	0.00202	CcSEcCtD
Olmesartan—Mental disorder—Memantine—Alzheimer's disease	0.00162	0.00201	CcSEcCtD
Olmesartan—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00161	0.00201	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00161	0.002	CcSEcCtD
Olmesartan—Malnutrition—Memantine—Alzheimer's disease	0.00161	0.002	CcSEcCtD
Olmesartan—Fatigue—Galantamine—Alzheimer's disease	0.00161	0.002	CcSEcCtD
Olmesartan—Malaise—Donepezil—Alzheimer's disease	0.0016	0.00199	CcSEcCtD
Olmesartan—Alopecia—Rivastigmine—Alzheimer's disease	0.00159	0.00199	CcSEcCtD
Olmesartan—Constipation—Galantamine—Alzheimer's disease	0.00159	0.00198	CcSEcCtD
Olmesartan—Vertigo—Donepezil—Alzheimer's disease	0.00159	0.00198	CcSEcCtD
Olmesartan—Syncope—Donepezil—Alzheimer's disease	0.00159	0.00198	CcSEcCtD
Olmesartan—Mental disorder—Rivastigmine—Alzheimer's disease	0.00158	0.00197	CcSEcCtD
Olmesartan—Malnutrition—Rivastigmine—Alzheimer's disease	0.00157	0.00196	CcSEcCtD
Olmesartan—Loss of consciousness—Donepezil—Alzheimer's disease	0.00155	0.00194	CcSEcCtD
Olmesartan—Back pain—Memantine—Alzheimer's disease	0.00155	0.00193	CcSEcCtD
Olmesartan—Cough—Donepezil—Alzheimer's disease	0.00154	0.00192	CcSEcCtD
Olmesartan—Feeling abnormal—Galantamine—Alzheimer's disease	0.00154	0.00191	CcSEcCtD
Olmesartan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00152	0.0019	CcSEcCtD
Olmesartan—Back pain—Rivastigmine—Alzheimer's disease	0.00152	0.00189	CcSEcCtD
Olmesartan—Vision blurred—Memantine—Alzheimer's disease	0.00151	0.00188	CcSEcCtD
Olmesartan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00151	0.00188	CcSEcCtD
Olmesartan—Arthralgia—Donepezil—Alzheimer's disease	0.00151	0.00188	CcSEcCtD
Olmesartan—Chest pain—Donepezil—Alzheimer's disease	0.00151	0.00188	CcSEcCtD
Olmesartan—Myalgia—Donepezil—Alzheimer's disease	0.00151	0.00188	CcSEcCtD
Olmesartan—Anxiety—Donepezil—Alzheimer's disease	0.0015	0.00187	CcSEcCtD
Olmesartan—Ill-defined disorder—Memantine—Alzheimer's disease	0.00149	0.00186	CcSEcCtD
Olmesartan—Discomfort—Donepezil—Alzheimer's disease	0.00149	0.00185	CcSEcCtD
Olmesartan—Anaemia—Memantine—Alzheimer's disease	0.00148	0.00185	CcSEcCtD
Olmesartan—Vision blurred—Rivastigmine—Alzheimer's disease	0.00148	0.00184	CcSEcCtD
Olmesartan—Agitation—Memantine—Alzheimer's disease	0.00148	0.00184	CcSEcCtD
Olmesartan—Abdominal pain—Galantamine—Alzheimer's disease	0.00147	0.00183	CcSEcCtD
Olmesartan—Body temperature increased—Galantamine—Alzheimer's disease	0.00147	0.00183	CcSEcCtD
Olmesartan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00146	0.00182	CcSEcCtD
Olmesartan—Anaemia—Rivastigmine—Alzheimer's disease	0.00145	0.00181	CcSEcCtD
Olmesartan—Malaise—Memantine—Alzheimer's disease	0.00145	0.0018	CcSEcCtD
Olmesartan—Agitation—Rivastigmine—Alzheimer's disease	0.00144	0.0018	CcSEcCtD
Olmesartan—Oedema—Donepezil—Alzheimer's disease	0.00144	0.0018	CcSEcCtD
Olmesartan—Vertigo—Memantine—Alzheimer's disease	0.00144	0.0018	CcSEcCtD
Olmesartan—Syncope—Memantine—Alzheimer's disease	0.00144	0.00179	CcSEcCtD
Olmesartan—Leukopenia—Memantine—Alzheimer's disease	0.00144	0.00179	CcSEcCtD
Olmesartan—Infection—Donepezil—Alzheimer's disease	0.00143	0.00179	CcSEcCtD
Olmesartan—Shock—Donepezil—Alzheimer's disease	0.00142	0.00177	CcSEcCtD
Olmesartan—Palpitations—Memantine—Alzheimer's disease	0.00142	0.00177	CcSEcCtD
Olmesartan—Malaise—Rivastigmine—Alzheimer's disease	0.00142	0.00176	CcSEcCtD
Olmesartan—Nervous system disorder—Donepezil—Alzheimer's disease	0.00142	0.00176	CcSEcCtD
Olmesartan—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00141	0.00176	CcSEcCtD
Olmesartan—Vertigo—Rivastigmine—Alzheimer's disease	0.00141	0.00176	CcSEcCtD
Olmesartan—Loss of consciousness—Memantine—Alzheimer's disease	0.00141	0.00176	CcSEcCtD
Olmesartan—Syncope—Rivastigmine—Alzheimer's disease	0.00141	0.00175	CcSEcCtD
Olmesartan—Cough—Memantine—Alzheimer's disease	0.0014	0.00175	CcSEcCtD
Olmesartan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.0014	0.00174	CcSEcCtD
Olmesartan—Palpitations—Rivastigmine—Alzheimer's disease	0.00139	0.00173	CcSEcCtD
Olmesartan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00138	0.00172	CcSEcCtD
Olmesartan—Anorexia—Donepezil—Alzheimer's disease	0.00138	0.00171	CcSEcCtD
Olmesartan—Cough—Rivastigmine—Alzheimer's disease	0.00137	0.00171	CcSEcCtD
Olmesartan—Myalgia—Memantine—Alzheimer's disease	0.00137	0.0017	CcSEcCtD
Olmesartan—Chest pain—Memantine—Alzheimer's disease	0.00137	0.0017	CcSEcCtD
Olmesartan—Arthralgia—Memantine—Alzheimer's disease	0.00137	0.0017	CcSEcCtD
Olmesartan—Anxiety—Memantine—Alzheimer's disease	0.00136	0.0017	CcSEcCtD
Olmesartan—Discomfort—Memantine—Alzheimer's disease	0.00135	0.00168	CcSEcCtD
Olmesartan—Hypotension—Donepezil—Alzheimer's disease	0.00135	0.00168	CcSEcCtD
Olmesartan—Arthralgia—Rivastigmine—Alzheimer's disease	0.00134	0.00167	CcSEcCtD
Olmesartan—Chest pain—Rivastigmine—Alzheimer's disease	0.00134	0.00167	CcSEcCtD
Olmesartan—Myalgia—Rivastigmine—Alzheimer's disease	0.00134	0.00167	CcSEcCtD
Olmesartan—Asthenia—Galantamine—Alzheimer's disease	0.00134	0.00166	CcSEcCtD
Olmesartan—Anxiety—Rivastigmine—Alzheimer's disease	0.00133	0.00166	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00133	0.00165	CcSEcCtD
Olmesartan—Discomfort—Rivastigmine—Alzheimer's disease	0.00132	0.00165	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00132	0.00164	CcSEcCtD
Olmesartan—Oedema—Memantine—Alzheimer's disease	0.00131	0.00163	CcSEcCtD
Olmesartan—Insomnia—Donepezil—Alzheimer's disease	0.00131	0.00163	CcSEcCtD
Olmesartan—Infection—Memantine—Alzheimer's disease	0.0013	0.00162	CcSEcCtD
Olmesartan—Shock—Memantine—Alzheimer's disease	0.00129	0.00161	CcSEcCtD
Olmesartan—Nervous system disorder—Memantine—Alzheimer's disease	0.00129	0.0016	CcSEcCtD
Olmesartan—Thrombocytopenia—Memantine—Alzheimer's disease	0.00128	0.0016	CcSEcCtD
Olmesartan—Oedema—Rivastigmine—Alzheimer's disease	0.00128	0.0016	CcSEcCtD
Olmesartan—Tachycardia—Memantine—Alzheimer's disease	0.00128	0.00159	CcSEcCtD
Olmesartan—Diarrhoea—Galantamine—Alzheimer's disease	0.00127	0.00159	CcSEcCtD
Olmesartan—Infection—Rivastigmine—Alzheimer's disease	0.00127	0.00159	CcSEcCtD
Olmesartan—Skin disorder—Memantine—Alzheimer's disease	0.00127	0.00159	CcSEcCtD
Olmesartan—Dyspepsia—Donepezil—Alzheimer's disease	0.00127	0.00158	CcSEcCtD
Olmesartan—Hyperhidrosis—Memantine—Alzheimer's disease	0.00127	0.00158	CcSEcCtD
Olmesartan—Shock—Rivastigmine—Alzheimer's disease	0.00126	0.00157	CcSEcCtD
Olmesartan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00126	0.00157	CcSEcCtD
Olmesartan—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00126	0.00156	CcSEcCtD
Olmesartan—Decreased appetite—Donepezil—Alzheimer's disease	0.00125	0.00156	CcSEcCtD
Olmesartan—Tachycardia—Rivastigmine—Alzheimer's disease	0.00125	0.00156	CcSEcCtD
Olmesartan—Anorexia—Memantine—Alzheimer's disease	0.00125	0.00156	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00125	0.00155	CcSEcCtD
Olmesartan—Skin disorder—Rivastigmine—Alzheimer's disease	0.00125	0.00155	CcSEcCtD
Olmesartan—Fatigue—Donepezil—Alzheimer's disease	0.00124	0.00155	CcSEcCtD
Olmesartan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00124	0.00154	CcSEcCtD
Olmesartan—Pain—Donepezil—Alzheimer's disease	0.00123	0.00154	CcSEcCtD
Olmesartan—Constipation—Donepezil—Alzheimer's disease	0.00123	0.00154	CcSEcCtD
Olmesartan—Dizziness—Galantamine—Alzheimer's disease	0.00123	0.00153	CcSEcCtD
Olmesartan—Hypotension—Memantine—Alzheimer's disease	0.00122	0.00153	CcSEcCtD
Olmesartan—Anorexia—Rivastigmine—Alzheimer's disease	0.00122	0.00152	CcSEcCtD
Olmesartan—Hypotension—Rivastigmine—Alzheimer's disease	0.0012	0.00149	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00119	0.00149	CcSEcCtD
Olmesartan—Feeling abnormal—Donepezil—Alzheimer's disease	0.00119	0.00148	CcSEcCtD
Olmesartan—Insomnia—Memantine—Alzheimer's disease	0.00119	0.00148	CcSEcCtD
Olmesartan—Vomiting—Galantamine—Alzheimer's disease	0.00118	0.00147	CcSEcCtD
Olmesartan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00118	0.00147	CcSEcCtD
Olmesartan—Rash—Galantamine—Alzheimer's disease	0.00117	0.00146	CcSEcCtD
Olmesartan—Dermatitis—Galantamine—Alzheimer's disease	0.00117	0.00146	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00117	0.00145	CcSEcCtD
Olmesartan—Headache—Galantamine—Alzheimer's disease	0.00117	0.00145	CcSEcCtD
Olmesartan—Insomnia—Rivastigmine—Alzheimer's disease	0.00116	0.00144	CcSEcCtD
Olmesartan—Dyspepsia—Memantine—Alzheimer's disease	0.00115	0.00144	CcSEcCtD
Olmesartan—Urticaria—Donepezil—Alzheimer's disease	0.00115	0.00143	CcSEcCtD
Olmesartan—Abdominal pain—Donepezil—Alzheimer's disease	0.00114	0.00142	CcSEcCtD
Olmesartan—Body temperature increased—Donepezil—Alzheimer's disease	0.00114	0.00142	CcSEcCtD
Olmesartan—Decreased appetite—Memantine—Alzheimer's disease	0.00114	0.00142	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00113	0.00141	CcSEcCtD
Olmesartan—Fatigue—Memantine—Alzheimer's disease	0.00113	0.00141	CcSEcCtD
Olmesartan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00113	0.00141	CcSEcCtD
Olmesartan—Pain—Memantine—Alzheimer's disease	0.00112	0.0014	CcSEcCtD
Olmesartan—Constipation—Memantine—Alzheimer's disease	0.00112	0.0014	CcSEcCtD
Olmesartan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00111	0.00139	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00111	0.00138	CcSEcCtD
Olmesartan—Nausea—Galantamine—Alzheimer's disease	0.00111	0.00138	CcSEcCtD
Olmesartan—Fatigue—Rivastigmine—Alzheimer's disease	0.00111	0.00138	CcSEcCtD
Olmesartan—Pain—Rivastigmine—Alzheimer's disease	0.0011	0.00137	CcSEcCtD
Olmesartan—Constipation—Rivastigmine—Alzheimer's disease	0.0011	0.00137	CcSEcCtD
Olmesartan—Feeling abnormal—Memantine—Alzheimer's disease	0.00108	0.00134	CcSEcCtD
Olmesartan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00107	0.00133	CcSEcCtD
Olmesartan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00106	0.00132	CcSEcCtD
Olmesartan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00105	0.00131	CcSEcCtD
Olmesartan—Urticaria—Memantine—Alzheimer's disease	0.00104	0.0013	CcSEcCtD
Olmesartan—Abdominal pain—Memantine—Alzheimer's disease	0.00104	0.00129	CcSEcCtD
Olmesartan—Body temperature increased—Memantine—Alzheimer's disease	0.00104	0.00129	CcSEcCtD
Olmesartan—Asthenia—Donepezil—Alzheimer's disease	0.00104	0.00129	CcSEcCtD
Olmesartan—Pruritus—Donepezil—Alzheimer's disease	0.00102	0.00127	CcSEcCtD
Olmesartan—Urticaria—Rivastigmine—Alzheimer's disease	0.00102	0.00127	CcSEcCtD
Olmesartan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00101	0.00126	CcSEcCtD
Olmesartan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00101	0.00126	CcSEcCtD
Olmesartan—Diarrhoea—Donepezil—Alzheimer's disease	0.000988	0.00123	CcSEcCtD
Olmesartan—Dizziness—Donepezil—Alzheimer's disease	0.000955	0.00119	CcSEcCtD
Olmesartan—Asthenia—Memantine—Alzheimer's disease	0.00094	0.00117	CcSEcCtD
Olmesartan—Pruritus—Memantine—Alzheimer's disease	0.000927	0.00115	CcSEcCtD
Olmesartan—Asthenia—Rivastigmine—Alzheimer's disease	0.00092	0.00115	CcSEcCtD
Olmesartan—Vomiting—Donepezil—Alzheimer's disease	0.000918	0.00114	CcSEcCtD
Olmesartan—Rash—Donepezil—Alzheimer's disease	0.00091	0.00113	CcSEcCtD
Olmesartan—Dermatitis—Donepezil—Alzheimer's disease	0.000909	0.00113	CcSEcCtD
Olmesartan—Pruritus—Rivastigmine—Alzheimer's disease	0.000907	0.00113	CcSEcCtD
Olmesartan—Headache—Donepezil—Alzheimer's disease	0.000904	0.00113	CcSEcCtD
Olmesartan—Diarrhoea—Memantine—Alzheimer's disease	0.000897	0.00112	CcSEcCtD
Olmesartan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000877	0.00109	CcSEcCtD
Olmesartan—Dizziness—Memantine—Alzheimer's disease	0.000867	0.00108	CcSEcCtD
Olmesartan—Nausea—Donepezil—Alzheimer's disease	0.000858	0.00107	CcSEcCtD
Olmesartan—Dizziness—Rivastigmine—Alzheimer's disease	0.000848	0.00106	CcSEcCtD
Olmesartan—Vomiting—Memantine—Alzheimer's disease	0.000833	0.00104	CcSEcCtD
Olmesartan—Rash—Memantine—Alzheimer's disease	0.000826	0.00103	CcSEcCtD
Olmesartan—Dermatitis—Memantine—Alzheimer's disease	0.000826	0.00103	CcSEcCtD
Olmesartan—Headache—Memantine—Alzheimer's disease	0.000821	0.00102	CcSEcCtD
Olmesartan—Vomiting—Rivastigmine—Alzheimer's disease	0.000815	0.00102	CcSEcCtD
Olmesartan—Rash—Rivastigmine—Alzheimer's disease	0.000809	0.00101	CcSEcCtD
Olmesartan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000808	0.00101	CcSEcCtD
Olmesartan—Headache—Rivastigmine—Alzheimer's disease	0.000803	0.001	CcSEcCtD
Olmesartan—Nausea—Memantine—Alzheimer's disease	0.000779	0.000969	CcSEcCtD
Olmesartan—Nausea—Rivastigmine—Alzheimer's disease	0.000762	0.000948	CcSEcCtD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000752	0.00409	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000739	0.00402	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00073	0.00397	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000725	0.00394	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.000718	0.0039	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000716	0.00389	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000694	0.00377	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000682	0.00371	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Alzheimer's disease	0.00068	0.00369	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000662	0.0036	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL1B—Alzheimer's disease	0.00065	0.00353	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CASP3—Alzheimer's disease	0.000648	0.00352	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—GAL—Alzheimer's disease	0.000642	0.00349	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000609	0.00331	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000606	0.00329	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000578	0.00314	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000563	0.00306	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.000555	0.00302	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.00055	0.00299	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—VEGFA—Alzheimer's disease	0.00055	0.00299	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000528	0.00287	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PYY—Alzheimer's disease	0.000523	0.00285	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000512	0.00278	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—HMOX1—Alzheimer's disease	0.000508	0.00276	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—Alzheimer's disease	0.000506	0.00275	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000505	0.00275	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TGFB1—Alzheimer's disease	0.000505	0.00274	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—NPY—Alzheimer's disease	0.000504	0.00274	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—IAPP—Alzheimer's disease	0.000501	0.00272	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.000492	0.00268	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000487	0.00265	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CRH—Alzheimer's disease	0.000487	0.00264	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—DHCR24—Alzheimer's disease	0.000484	0.00263	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—F2—Alzheimer's disease	0.000482	0.00262	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000481	0.00261	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.000476	0.00259	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PYY—Alzheimer's disease	0.000475	0.00258	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TNF—Alzheimer's disease	0.000471	0.00256	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—NPS—Alzheimer's disease	0.000461	0.00251	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—AGER—Alzheimer's disease	0.000456	0.00248	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000451	0.00245	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—SST—Alzheimer's disease	0.00044	0.00239	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000437	0.00237	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000435	0.00237	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000435	0.00236	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.000431	0.00235	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—APP—Alzheimer's disease	0.000429	0.00233	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000425	0.00231	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000424	0.00231	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CDK5—Alzheimer's disease	0.000412	0.00224	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CA4—Alzheimer's disease	0.000411	0.00224	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000409	0.00222	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000402	0.00218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR6—Alzheimer's disease	0.000397	0.00216	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000393	0.00214	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GAPDHS—Alzheimer's disease	0.000387	0.0021	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000382	0.00208	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000372	0.00202	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ATP5A1—Alzheimer's disease	0.000367	0.00199	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000364	0.00198	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GAL—Alzheimer's disease	0.000363	0.00197	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLD3—Alzheimer's disease	0.00035	0.0019	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.00035	0.0019	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000346	0.00188	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HSD17B10—Alzheimer's disease	0.000335	0.00182	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GAL—Alzheimer's disease	0.000329	0.00179	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000328	0.00178	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000325	0.00177	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—DHCR24—Alzheimer's disease	0.000325	0.00177	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP46A1—Alzheimer's disease	0.000323	0.00175	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TTR—Alzheimer's disease	0.000321	0.00175	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000319	0.00174	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ND1—Alzheimer's disease	0.000312	0.00169	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000305	0.00166	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000303	0.00165	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPY—Alzheimer's disease	0.000285	0.00155	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000285	0.00155	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000284	0.00154	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000283	0.00154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PYY—Alzheimer's disease	0.000281	0.00153	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000279	0.00151	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000277	0.00151	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CA4—Alzheimer's disease	0.000276	0.0015	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CRH—Alzheimer's disease	0.000275	0.00149	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000273	0.00149	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.00027	0.00147	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000261	0.00142	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GAPDHS—Alzheimer's disease	0.00026	0.00141	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPY—Alzheimer's disease	0.000259	0.00141	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000257	0.0014	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000257	0.0014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CRH—Alzheimer's disease	0.00025	0.00136	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000249	0.00135	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—SST—Alzheimer's disease	0.000249	0.00135	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ATP5A1—Alzheimer's disease	0.000246	0.00134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDK5—Alzheimer's disease	0.000243	0.00132	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—F2—Alzheimer's disease	0.000243	0.00132	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—APP—Alzheimer's disease	0.000242	0.00132	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.00024	0.00131	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPS—Alzheimer's disease	0.000237	0.00129	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000236	0.00128	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLD3—Alzheimer's disease	0.000235	0.00128	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000235	0.00128	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR6—Alzheimer's disease	0.000234	0.00127	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000232	0.00126	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000232	0.00126	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000229	0.00124	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000227	0.00124	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—SST—Alzheimer's disease	0.000226	0.00123	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000226	0.00123	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD17B10—Alzheimer's disease	0.000225	0.00122	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.00022	0.0012	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—APP—Alzheimer's disease	0.00022	0.0012	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000219	0.00119	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000218	0.00119	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000217	0.00118	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP46A1—Alzheimer's disease	0.000217	0.00118	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000213	0.00116	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APH1A—Alzheimer's disease	0.00021	0.00114	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ND1—Alzheimer's disease	0.000209	0.00114	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000208	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000205	0.00111	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000204	0.00111	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TPI1—Alzheimer's disease	0.000201	0.00109	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CHAT—Alzheimer's disease	0.000201	0.00109	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LRP1—Alzheimer's disease	0.000199	0.00108	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GAL—Alzheimer's disease	0.000195	0.00106	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GFAP—Alzheimer's disease	0.000195	0.00106	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—TGFB1—Alzheimer's disease	0.000193	0.00105	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MAOB—Alzheimer's disease	0.000193	0.00105	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000187	0.00102	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GAPDH—Alzheimer's disease	0.000185	0.00101	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000183	0.000996	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000182	0.000987	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—A2M—Alzheimer's disease	0.000179	0.000973	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—A2M—Alzheimer's disease	0.000172	0.000932	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000171	0.000928	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000169	0.000919	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000166	0.000903	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000163	0.000884	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000161	0.000877	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.00016	0.000871	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.00016	0.000868	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000157	0.000852	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ACHE—Alzheimer's disease	0.000156	0.000846	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—INPP5D—Alzheimer's disease	0.000154	0.000837	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000154	0.000835	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPY—Alzheimer's disease	0.000153	0.000831	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000153	0.00083	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IAPP—Alzheimer's disease	0.000152	0.000826	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CRH—Alzheimer's disease	0.000148	0.000802	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000147	0.000798	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ENO1—Alzheimer's disease	0.000146	0.000793	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS1—Alzheimer's disease	0.000146	0.000793	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000146	0.000791	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2D6—Alzheimer's disease	0.000143	0.000778	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000142	0.000774	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPS—Alzheimer's disease	0.00014	0.00076	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000139	0.000756	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2—Alzheimer's disease	0.000137	0.000747	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000137	0.000745	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—BCHE—Alzheimer's disease	0.000136	0.000737	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CHAT—Alzheimer's disease	0.000135	0.000733	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TPI1—Alzheimer's disease	0.000135	0.000733	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GAB2—Alzheimer's disease	0.000133	0.000725	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000133	0.000725	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SST—Alzheimer's disease	0.000133	0.000725	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000133	0.000722	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000132	0.000719	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APP—Alzheimer's disease	0.00013	0.000707	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MAOB—Alzheimer's disease	0.000129	0.000703	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLCB1—Alzheimer's disease	0.000128	0.000696	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000126	0.000683	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2—Alzheimer's disease	0.000125	0.000679	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GAPDH—Alzheimer's disease	0.000125	0.000677	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCA1—Alzheimer's disease	0.000124	0.000674	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000123	0.000669	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000123	0.000667	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000122	0.000663	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—A2M—Alzheimer's disease	0.00012	0.000654	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGFR—Alzheimer's disease	0.000114	0.000622	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CREB1—Alzheimer's disease	0.000114	0.000618	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADAM10—Alzheimer's disease	0.000112	0.000608	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—Alzheimer's disease	0.000111	0.000605	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000107	0.000583	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARGC1A—Alzheimer's disease	0.000107	0.000581	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—Alzheimer's disease	0.000106	0.000579	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—S100B—Alzheimer's disease	0.000106	0.000575	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACHE—Alzheimer's disease	0.000105	0.000569	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—INPP5D—Alzheimer's disease	0.000103	0.000562	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF2—Alzheimer's disease	0.000101	0.000547	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ENO1—Alzheimer's disease	9.8e-05	0.000533	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS1—Alzheimer's disease	9.8e-05	0.000533	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPL—Alzheimer's disease	9.74e-05	0.000529	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1R—Alzheimer's disease	9.73e-05	0.000529	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2D6—Alzheimer's disease	9.61e-05	0.000523	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LPL—Alzheimer's disease	9.33e-05	0.000507	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MEF2C—Alzheimer's disease	9.25e-05	0.000503	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BCHE—Alzheimer's disease	9.11e-05	0.000495	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCG—Alzheimer's disease	9.07e-05	0.000493	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGF—Alzheimer's disease	8.84e-05	0.00048	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—Alzheimer's disease	8.77e-05	0.000477	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLCB1—Alzheimer's disease	8.6e-05	0.000468	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—Alzheimer's disease	8.6e-05	0.000467	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.44e-05	0.000459	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2A—Alzheimer's disease	8.41e-05	0.000457	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCA1—Alzheimer's disease	8.34e-05	0.000453	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CALM1—Alzheimer's disease	8.19e-05	0.000445	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOE—Alzheimer's disease	8.16e-05	0.000444	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAV1—Alzheimer's disease	8.09e-05	0.00044	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CALM1—Alzheimer's disease	7.85e-05	0.000427	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—Alzheimer's disease	7.82e-05	0.000425	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOE—Alzheimer's disease	7.82e-05	0.000425	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CAV1—Alzheimer's disease	7.75e-05	0.000421	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ESR1—Alzheimer's disease	7.47e-05	0.000406	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2—Alzheimer's disease	7.37e-05	0.000401	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.22e-05	0.000392	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARGC1A—Alzheimer's disease	7.18e-05	0.000391	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—Alzheimer's disease	7.15e-05	0.000389	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—Alzheimer's disease	7.11e-05	0.000386	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—INS—Alzheimer's disease	6.97e-05	0.000379	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GSK3B—Alzheimer's disease	6.77e-05	0.000368	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CREB1—Alzheimer's disease	6.72e-05	0.000365	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—INS—Alzheimer's disease	6.68e-05	0.000363	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—Alzheimer's disease	6.57e-05	0.000357	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPL—Alzheimer's disease	6.54e-05	0.000356	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—Alzheimer's disease	6.46e-05	0.000351	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—Alzheimer's disease	6.11e-05	0.000332	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—Alzheimer's disease	5.89e-05	0.00032	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—Alzheimer's disease	5.86e-05	0.000318	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—Alzheimer's disease	5.59e-05	0.000304	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CALM1—Alzheimer's disease	5.5e-05	0.000299	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOE—Alzheimer's disease	5.48e-05	0.000298	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAV1—Alzheimer's disease	5.43e-05	0.000295	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.02e-05	0.000273	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—Alzheimer's disease	4.97e-05	0.00027	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—Alzheimer's disease	4.94e-05	0.000269	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—Alzheimer's disease	4.78e-05	0.00026	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—INS—Alzheimer's disease	4.68e-05	0.000255	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK8—Alzheimer's disease	4.57e-05	0.000249	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—Alzheimer's disease	4.56e-05	0.000248	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—Alzheimer's disease	4.22e-05	0.000229	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—Alzheimer's disease	4.11e-05	0.000223	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—Alzheimer's disease	3.87e-05	0.000211	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—Alzheimer's disease	3.76e-05	0.000204	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—Alzheimer's disease	3.19e-05	0.000173	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—Alzheimer's disease	2.92e-05	0.000159	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—Alzheimer's disease	2.81e-05	0.000153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—Alzheimer's disease	2.69e-05	0.000146	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—Alzheimer's disease	1.89e-05	0.000103	CbGpPWpGaD
